C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/16 (2006.01) A61K 38/46 (2006.01) A61P 3/10 (2006.01) A61P 37/06 (2006.01) C07K 1/22 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/00 (2006.01) C07K 14/47 (2006.01) C40B 30/04 (2006.01) G01N 33/567 (2006.01) C07K 14/74 (2006.01)
Patent
CA 2758956
The invention provides methods for identifying peptide epitopes that activate CD4+ T cells involved in the pathogenesis of diseases, e.g., autoimmune diseases, susceptibility to which is determined by expression of particular class II MHC genes. The invention includes peptides derived from the IA-2 polypeptide by such a method, altered peptide ligands, and methods of therapy involving the use of altered peptide ligands.
Chicz Roman M.
Peakman Mark
Eisai Inc.
King's College London
Smart & Biggar
LandOfFree
Peptide epitopes recognized by disease promoting cd4+ t... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide epitopes recognized by disease promoting cd4+ t..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide epitopes recognized by disease promoting cd4+ t... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1947952